Suppr超能文献

丹酚酸 B 通过刺激成骨和骨髓血管生成预防泼尼松治疗大鼠的骨丢失。

Salvianolic acid B prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesis.

机构信息

Department of Pharmacology, Guangdong Key Laboratory for Research and Development of Natural Drug, Guangdong Medical College, Zhanjiang City, Guangdong, China.

出版信息

PLoS One. 2012;7(4):e34647. doi: 10.1371/journal.pone.0034647. Epub 2012 Apr 6.

Abstract

Glucocorticoid (GC) induced osteoporosis (GIO) is caused by the long-term use of GC for treatment of autoimmune and inflammatory diseases. The GC related disruption of bone marrow microcirculation and increased adipogenesis contribute to GIO development. However, neither currently available anti-osteoporosis agent is completely addressed to microcirculation and bone marrow adipogenesis. Salvianolic acid B (Sal B) is a polyphenolic compound from a Chinese herbal medicine, Salvia miltiorrhiza Bunge. The aim of this study was to determine the effects of Sal B on osteoblast bone formation, angiogenesis and adipogenesis-associated GIO by performing marrow adipogenesis and microcirculation dilation and bone histomorphometry analyses. (1) In vivo study: Bone loss in GC treated rats was confirmed by significantly decreased BMD, bone strength, cancellous bone mass and architecture, osteoblast distribution, bone formation, marrow microvessel density and diameter along with down-regulation of marrow BMPs expression and increased adipogenesis. Daily treatment with Sal B (40 mg/kg/d) for 12 weeks in GC male rats prevented GC-induced cancellous bone loss and increased adipogenesis while increasing cancellous bone formation rate with improved local microcirculation by capillary dilation. Treatment with Sal B at a higher dose (80 mg/kg/d) not only prevented GC-induced osteopenia, but also increased cancellous bone mass and thickness, associated with increase of marrow BMPs expression, inhibited adipogenesis and further increased microvessel diameters. (2) In vitro study: In concentration from 10(-6) mol/L to 10(-7) mol/L, Sal B stimulated bone marrow stromal cell (MSC) differentiation to osteoblast and increased osteoblast activities, decreased GC associated adipogenic differentiation by down-regulation of PPARγ mRNA expression, increased Runx2 mRNA expression without osteoblast inducement, and, furthermore, Sal B decreased Dickkopf-1 and increased β-catenin mRNA expression with or without adipocyte inducement in MSC. We conclude that Sal B prevented bone loss in GC-treated rats through stimulation of osteogenesis, bone marrow angiogenesis and inhibition of adipogenesis.

摘要

糖皮质激素(GC)诱导性骨质疏松症(GIO)是由于长期使用 GC 治疗自身免疫性和炎症性疾病引起的。GC 相关的骨髓微循环破坏和脂肪生成增加导致 GIO 的发展。然而,目前可用的抗骨质疏松药物都不能完全解决微循环和骨髓脂肪生成的问题。丹酚酸 B(Sal B)是一种来自中药丹参的多酚化合物。本研究旨在通过骨髓脂肪生成和微血管扩张以及骨组织形态计量学分析,确定 Sal B 对成骨细胞骨形成、血管生成和脂肪生成相关 GIO 的影响。(1)体内研究:GC 处理大鼠的骨丢失通过明显降低骨密度、骨强度、松质骨量和结构、成骨细胞分布、骨形成、骨髓微血管密度和直径以及下调骨髓 BMPs 表达和增加脂肪生成来证实。GC 雄性大鼠每天给予 Sal B(40mg/kg/d)治疗 12 周可预防 GC 诱导的松质骨丢失和脂肪生成增加,同时通过毛细血管扩张改善局部微循环,增加松质骨形成率。高剂量(80mg/kg/d)Sal B 治疗不仅预防 GC 引起的骨质疏松症,而且增加松质骨量和厚度,与骨髓 BMPs 表达增加、抑制脂肪生成和进一步增加微血管直径相关。(2)体外研究:在 10(-6)mol/L 至 10(-7)mol/L 的浓度范围内,Sal B 刺激骨髓基质细胞(MSC)向成骨细胞分化,并增加成骨细胞活性,通过下调 PPARγmRNA 表达抑制 GC 相关的脂肪生成分化,增加 Runx2mRNA 表达而不诱导成骨细胞,并且,Sal B 在 MSC 中有或没有脂肪细胞诱导时降低 Dickkopf-1 并增加β-catenin mRNA 表达。我们得出结论,Sal B 通过刺激成骨、骨髓血管生成和抑制脂肪生成来预防 GC 治疗大鼠的骨丢失。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c8e/3321026/3cf081e16f46/pone.0034647.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验